Ondansetron for the Treatment of Cocaine Dependence - 1

Completed · Phase 2

Conditions studied: Cocaine-Related Disorders, Drug Administration Schedule

In brief

The purpose of this study is to assess the efficacy and safety of ondansetron to reduce cocaine use in subjects with cocaine dependence.

Key facts

Study ID

NCT00033085

Run by

National Institute on Drug Abuse (NIDA)

People needed

60

Starts

2001-05-01

Expected to finish

2002-12-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male/Female, at least 18 yrs of age; DSM-4 diagnosis of cocaine dependence; seeking Treatment for cocaine dependence; have ability to understand, having understood and provide written consent; females of child bearing potential that use accepted method of birth control

You may not qualify if…

• Additional criteria available during screening at the site.

Where it is running

• University of Texas Hlth Sci Ctr San Ant — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.